There are mixed messages about the health effects of drinking some alcohol. Scientific evidence can help you weigh the risks and benefits, but it’s clear that having more than a few drinks per week appears to increase breast cancer risk. Read more in our latest Komen Perspectives Article.
Telling lawmakers that “This is where the ribbon meets the road,” our Founder and CEO Nancy Brinker kicked off the Komen Advocacy Alliance Lobby Day in Washington, D.C. this morning, with hundreds of our Affiliate and Advocacy Alliance representatives on hand to fight for breast cancer issues.
As in years past, advocates in pink streamed across Capitol Hill urging lawmakers to preserve early detection and treatment programs, especially for vulnerable groups such as the poor and uninsured, and to maintain federal investments in cancer research.
It was a standing-room-only crowd as about 40 congressional members joined advocates for the launch breakfast this morning. Nancy acknowledged the difficulty lawmakers will have in tough budgetary times and pledged partnership saying “We’re not here just with our hands out, but extending our hands in partnership to help save lives.”
She took the opportunity to announce our $58 million in research funding for 2011, going to 80 grants at 56 institutions worldwide. We have more information about our 2011 research grants slate here.
Be sure to check out the pictures from our event this morning in the slideshow below.
We are really excited today to announce $58 million for new research through our 2011 Susan G. Komen for the Cure grants program. Some $55 million will go to 80 research projects and another $3 million will fund patient support programs and conferences.
You can find the full slate here, but we’d like to call out our two big Promise Grants for 2011. Promise Grants are the multi-million dollar, multi-year grants we launched in 2008, designed to get theories out of the lab and to the bedside quickly. With today’s announcement, we now have 16 of these large grants being funded, with 16 clinical trials either underway or on tap for the coming year.
New this year is a $6.5 million Promise Grant to the University of California at San Francisco to look at genetic interventions to the immune system to treat triple negative breast cancer – an aggressive form of the disease more commonly diagnosed in African American women. In St. Louis, a $6.5 million grant to researchers at Washington University could lead to a personalized vaccine to prevent the recurrence of breast cancer.
Imagine that. A personalized vaccine that could keep cancer from coming back. That would be a big breakthrough, and that’s what we’re after – big breakthroughs. We’ve been after them since we began funding research nearly 30 years ago, and with $610 million invested to date, we’re proud to say that we’ve touched every major advance in breast cancer science since then.
The research is getting results: mortality rates have declined by 31% in the U.S. since 1990, 5-year U.S. survival rates are 98% for early stage breast cancers, and there are today more effective treatments for many women with this disease.
But as we all know, there’s a lot left to understand, so we’re going after the really tough questions: how breast cancer forms, how it grows and spreads, how to stop it if it does spread, why some racial or ethnic groups have worse outcomes from the disease, and whether it’s possible to prevent breast cancer entirely.
Your support will help us get to those answers – hopefully very soon. Thanks for all that you do to help save lives.
We are proud and humbled to share the news that we have again earned Charity Navigator’s prestigious four-star rating for the fifth year in a row, a feat accomplished by only 5% of the nation’s nonprofit organizations. This rating assures all of our current and potential donors that we consistently excel in financial stewardship of donors’ funds. And if that isn’t enough reason to celebrate, we have been ranked among the top two nonprofits in terms of brand equity and as a charity people are most likely to donate to by The Harris EquiTrend® poll. The Harris poll has listed us in the top 10 of the nation’s most trusted nonprofits, too.
“This is an important statement to the individuals and partners who support our work to fuel the best science and make the biggest impact in communities across this country. We believe that it is our responsibility to not only lead the breast cancer movement, but also to set the standard for stewardship of the funds that are entrusted to us,” our founder and CEO Ambassador Nancy G. Brinker said of these honors.
Thank you to all who are helping to fulfill our promise to save lives and end breast cancer forever. Together we’ll see this promise through to the end.
In Nigeria, as many as half of women who need breast cancer surgery are turning it down. In Mexico, women may wait up to six months to find out if they have breast cancer once they suspect it. These are just some of the findings of newly published findings in the April 1 edition of The Breast, a report by the Breast Health Global Initiative, operated by the Fred Hutchinson Cancer Center in partnership with Susan G. Komen for the Cure. Consensus statements and 11 research papers were based on projects presented last June at the Breast Health Global Initiative Summit last June in Chicago. An executive summary of the consensus statements was published simultaneously in the April 1 edition of The Lancet Oncology. More information is located here.